During 2015, Sheridan Company purchased a building site for its proposed research and development laboratory at a cost of $59,000. Construction of the building was started in 2015. The building was completed on December 31, 2016, at a cost of $400,000 and was placed in service on January 2, 2017. The estimated useful life of the building for depreciation purposes was 20 years. The straight-line method of depreciation was to be employed, and there was no estimated residual value. Management estimates that about 50% of the projects of the research and development group will result in long-term benefits (i.e., at least 10 years) to the corporation. The remaining projects either benefit the current period or are abandoned before completion. A summary of the number of projects and the direct costs incurred in conjunction with the research and development activities for 2017 appears below. Number of Projects Salaries and Employee Benefits Other Expenses (excluding Building Depreciation Charges) Completed projects with long-term benefits 20 $92,000 $46,000 Abandoned projects or projects that benefit the current period 13 64,000 12,000 Projects in process—results indeterminate 7 47,000 9,000 Total 40 $203,000 $67,000 Upon recommendation of the research and development group, Sheridan Company acquired a patent for manufacturing rights at a cost of $92,000. The patent was acquired on April 1, 2016, and has an economic life of 10 years. If generally accepted accounting principles were followed, how would the items above relating to research and development activities be reported on the following financial statements? The company’s income statement for 2017. (Do not round intermediate calculations and round final answer to 0 decimal places, e.g. 5,275.) Sheridan Company Income Statement (Partial) $ The company’s balance sheet as of December 31, 2017. (Do not round intermediate calculations and round final answer to 0 decimal places, e.g. 5,275.) Sheridan Company Balance Sheet (Partial) For the Year Ended December 31, 2017 $
During 2015, Sheridan Company purchased a building site for its proposed research and development laboratory at a cost of $59,000. Construction of the building was started in 2015. The building was completed on December 31, 2016, at a cost of $400,000 and was placed in service on January 2, 2017. The estimated useful life of the building for depreciation purposes was 20 years. The straight-line method of depreciation was to be employed, and there was no estimated residual value. Management estimates that about 50% of the projects of the research and development group will result in long-term benefits (i.e., at least 10 years) to the corporation. The remaining projects either benefit the current period or are abandoned before completion. A summary of the number of projects and the direct costs incurred in conjunction with the research and development activities for 2017 appears below. Number of Projects Salaries and Employee Benefits Other Expenses (excluding Building Depreciation Charges) Completed projects with long-term benefits 20 $92,000 $46,000 Abandoned projects or projects that benefit the current period 13 64,000 12,000 Projects in process—results indeterminate 7 47,000 9,000 Total 40 $203,000 $67,000 Upon recommendation of the research and development group, Sheridan Company acquired a patent for manufacturing rights at a cost of $92,000. The patent was acquired on April 1, 2016, and has an economic life of 10 years. If generally accepted accounting principles were followed, how would the items above relating to research and development activities be reported on the following financial statements? The company’s income statement for 2017. (Do not round intermediate calculations and round final answer to 0 decimal places, e.g. 5,275.) Sheridan Company Income Statement (Partial) $ The company’s balance sheet as of December 31, 2017. (Do not round intermediate calculations and round final answer to 0 decimal places, e.g. 5,275.) Sheridan Company Balance Sheet (Partial) For the Year Ended December 31, 2017 $
During 2015, Sheridan Company purchased a building site for its proposed research and development laboratory at a cost of $59,000. Construction of the building was started in 2015. The building was completed on December 31, 2016, at a cost of $400,000 and was placed in service on January 2, 2017. The estimated useful life of the building for depreciation purposes was 20 years. The straight-line method of depreciation was to be employed, and there was no estimated residual value. Management estimates that about 50% of the projects of the research and development group will result in long-term benefits (i.e., at least 10 years) to the corporation. The remaining projects either benefit the current period or are abandoned before completion. A summary of the number of projects and the direct costs incurred in conjunction with the research and development activities for 2017 appears below. Number of Projects Salaries and Employee Benefits Other Expenses (excluding Building Depreciation Charges) Completed projects with long-term benefits 20 $92,000 $46,000 Abandoned projects or projects that benefit the current period 13 64,000 12,000 Projects in process—results indeterminate 7 47,000 9,000 Total 40 $203,000 $67,000 Upon recommendation of the research and development group, Sheridan Company acquired a patent for manufacturing rights at a cost of $92,000. The patent was acquired on April 1, 2016, and has an economic life of 10 years. If generally accepted accounting principles were followed, how would the items above relating to research and development activities be reported on the following financial statements? The company’s income statement for 2017. (Do not round intermediate calculations and round final answer to 0 decimal places, e.g. 5,275.) Sheridan Company Income Statement (Partial) $ The company’s balance sheet as of December 31, 2017. (Do not round intermediate calculations and round final answer to 0 decimal places, e.g. 5,275.) Sheridan Company Balance Sheet (Partial) For the Year Ended December 31, 2017 $
During 2015, Sheridan Company purchased a building site for its proposed research and development laboratory at a cost of $59,000. Construction of the building was started in 2015. The building was completed on December 31, 2016, at a cost of $400,000 and was placed in service on January 2, 2017. The estimated useful life of the building for depreciation purposes was 20 years. The straight-line method of depreciation was to be employed, and there was no estimated residual value.
Management estimates that about 50% of the projects of the research and development group will result in long-term benefits (i.e., at least 10 years) to the corporation. The remaining projects either benefit the current period or are abandoned before completion. A summary of the number of projects and the direct costs incurred in conjunction with the research and development activities for 2017 appears below.
Number of Projects
Salaries and Employee Benefits
Other Expenses (excluding Building Depreciation Charges)
Completed projects with long-term benefits
20
$92,000
$46,000
Abandoned projects or projects that
benefit the current period
13
64,000
12,000
Projects in process—results indeterminate
7
47,000
9,000
Total
40
$203,000
$67,000
Upon recommendation of the research and development group, Sheridan Company acquired a patent for manufacturing rights at a cost of $92,000. The patent was acquired on April 1, 2016, and has an economic life of 10 years.
If generally accepted accounting principles were followed, how would the items above relating to research and development activities be reported on the following financial statements?
The company’s income statement for 2017. (Do not round intermediate calculations and round final answer to 0 decimal places, e.g. 5,275.)
Sheridan Company Income Statement (Partial)
$
The company’s balance sheet as of December 31, 2017. (Do not round intermediate calculations and round final answer to 0 decimal places, e.g. 5,275.)
Sheridan Company Balance Sheet (Partial)
For the Year Ended December 31, 2017
$
Definition Definition Financial statement that provides a snapshot of an organization's financial position at a specific point in time. It summarizes a company's assets, liabilities, and shareholder's equity, detailing what the company owns, what it owes, and what is left over for its owners. The balance sheet serves as a crucial tool to assess the financial health and stability of a company, as well as to help management make informed decisions about its future investments and financial obligations.
Expert Solution
Step 1
Research and development expenses are those expenses which are incurred for the research of any plan and developing the idea by using the resources.
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.